focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNL.L Share News (DNL)

  • There is currently no data for DNL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: K3 director linked to purchase, Diurnal exec sells shares into ISA

Mon, 09th May 2022 14:01

(Sharecast News) - Software company K3 Business Technology was at the top of the list of buys on Monday, after Kestrel Partners spent more than £40k on its shares.

The AIM-traded firm said Kestrel Partners, on behalf of its discretionary clients, bought 27,129 shares for 150p each, spending a total of £40,693.50.

Its non-executive director Oliver Scott is a partner of, and holds a beneficial interest in Kestrel, and is also a shareholder in one of Kestrel's clients, Kestrel Opportunities, and so has a beneficial interest in Kestrel Opportunities' entire legal holding in the company.

Following the purchase, K3 said Kestrel Opportunities held 8,515,879 of its shares, and other clients of Kestrel in which Scott had no beneficial interest held 2,775,101 shares.

In total, Kestrel indirectly held voting rights over 11,290,980 of K3's shares, representing 25.24% percent of its issued share capital.

On the selling side of the ledger, specialty pharmaceutical company Diurnal Group disclosed a sale worth over £40k made by its chief scientific officer.

The AIM-traded firm said Richard Ross sold 312,000 shares for 13p each, while his and his wife's individual savings accounts (ISAs) purchased 153,500 and 153,500 shares, respectively, at a price of 13.01p each.

Following the transactions, the total beneficial interest of Richard Ross and his connected parties was 2,257,155 shares, representing 1.33% of Diurnal's total voting rights as of 9 May.

Top Director Buys

K3 Business Technology Group (KBT)

Director name: Scott,Oliver Rupert Andrew

Amount purchased: 27,129 @ 150.00p

Value: £40,693.50

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Diurnal Group (DNL)

Director name: Ross,Richard

Amount purchased: 153,500 @ 13.01p

Value: £19,970.35

Discoverie Group (DSCV)

Director name: Watson ,Clive

Amount purchased: 2,875 @ 690.00p

Value: £19,837.50

Henderson Smaller Companies Inv Trust (HSL)

Director name: Carter,Kevin

Amount purchased: 1,500 @ 868.36p

Value: £13,025.39

Target Healthcare Reit Ltd (THRL)

Director name: Fyfe,Alison

Amount purchased: 10,000 @ 109.80p

Value: £10,980.00

Mgc Pharmaceuticals Limited Npv (di) (MXC)

Director name: Zomer,Roby

Amount purchased: 819,672 @ 1.30p

Value: £10,655.74

Parity Group (PTY)

Director name: Johns,Mike

Amount purchased: 139,082 @ 7.19p

Value: £10,000.00

Mondi (MNDI)

Director name: Strank,Angela

Amount purchased: 628 @ 1,579.95p

Value: £9,922.08

Henderson Smaller Companies Inv Trust (HSL)

Director name: Freer,Penelope Anne

Amount purchased: 1,000 @ 878.92p

Value: £8,789.20

Reach (RCH)

Director name: Panayi,Barry

Amount purchased: 3,979 @ 124.72p

Value: £4,962.77

Capita (CPI)

Director name: Murphy,Joseph

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Lewis,Jonathan (Jon)

Amount purchased: 643 @ 26.83p

Value: £172.52

Capita (CPI)

Director name: Weller,Tim

Amount purchased: 643 @ 26.83p

Value: £172.52

Assura (AGR)

Director name: Cottam,Jayne

Amount purchased: 228 @ 66.16p

Value: £150.84

Assura (AGR)

Director name: Murphy,Jonathan

Amount purchased: 228 @ 66.16p

Value: £150.84

Top Director Sells

Rolls-royce Holdings (RR.)

Director name: East,Warren

Amount sold: 210,515 @ 83.78p

Value: £176,369.47

Diurnal Group (DNL)

Director name: Ross,Richard

Amount sold: 312,000 @ 13.00p

Value: £40,560.00

More News
11 May 2020 13:07

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

UK EXECUTIVE CHANGE SUMMARY: Abcam Board Confirms Support For Chair

Read more
15 Apr 2020 14:32

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

UK TRADING UPDATE SUMMARY: Kromek To Make 2,000 Ventilators For UK

Read more
1 Apr 2020 14:47

Diurnal Gets European Marketing Authorisation For Chronocort

Diurnal Gets European Marketing Authorisation For Chronocort

Read more
6 Mar 2020 17:12

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

UPDATE: Diurnal Placing Raises GBP11 Million For Drug Development

Read more
6 Mar 2020 12:40

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Diurnal Announces GBP7 Million Placing To Fund Drug Development

Read more
6 Mar 2020 10:07

Diurnal raises at least ?7m through conditional placing

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced a conditional placing with institutional investors on Friday, to raise at least ?7m before expenses, at a price of 32p per new share.

Read more
5 Mar 2020 17:21

Diurnal Group Names Director Sam Williams Interim Chair

Diurnal Group Names Director Sam Williams Interim Chair

Read more
13 Feb 2020 13:07

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Diurnal Says US FDA Accepts New Drug Application For Alkindi Sprinkle

Read more
13 Feb 2020 09:47

Diurnal clears FDA hurdle for 'Alkindi Sprinkle'

(Sharecast News) - Speciality pharmaceutical company Diurnal Group announced on Thursday that its new drug application (NDA) for 'Alkindi', or hydrocortisone granules in capsules for opening and to be known in the US as 'Alkindi Sprinkle', has been accepted for review by the US Food and Drug Administration (FDA).

Read more
11 Feb 2020 13:45

Diurnal narrows loss as it progresses drugs to market

(Sharecast News) - Speciality pharmaceutical company Diurnal Group narrowed its first-half loss by 53% to ?4.6m, it announced on Tuesday, which it said reflected improved revenues and a reduction in clinical development expenses for the period.

Read more
11 Feb 2020 09:20

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Diurnal Loss Narrows In First Half Amid Improved Sales Of Alkindi

Read more
4 Feb 2020 15:54

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
20 Jan 2020 11:17

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Diurnal In Good Health Ahead Of Second Half Amid Alkindi Progress

Read more
16 Dec 2019 13:20

Diurnal Submits Market Authorisation Application For Chronocort

Diurnal Submits Market Authorisation Application For Chronocort

Read more
2 Dec 2019 14:40

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Diurnal Submits New Drug Application For Aklindi Sprinkle In US

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.